# Study of a Levonorgestrel 52 mg Intrauterine System for the Treatment of Heavy Menstrual Bleeding

> **NCT03642210** · PHASE3 · COMPLETED · sponsor: **Medicines360** · enrollment: 105 (actual)

## Conditions studied

- Menorrhagia

## Interventions

- **COMBINATION_PRODUCT:** Levonorgestrel 52 mg intrauterine system

## Key facts

- **NCT ID:** NCT03642210
- **Lead sponsor:** Medicines360
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-17
- **Primary completion:** 2021-10-12
- **Final completion:** 2021-10-12
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2024-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03642210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03642210, "Study of a Levonorgestrel 52 mg Intrauterine System for the Treatment of Heavy Menstrual Bleeding". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03642210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*